Home › Companies › MacroGenics, Inc. › 2025-2026
At MacroGenics, Inc.'s shareholder meeting held May 19, 2026, in the 2025-2026 proxy season, 94 asset managers reported how they voted in their SEC Form N-PX filings, covering 405 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — MacroGenics, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MacroGenics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 20, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and MacroGenics, Inc.’s Form 8-K, filed May 20, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 19, 2026: 6 items on MacroGenics, Inc.’s Form 8-K, filed May 20, 2026: 3 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore MacroGenics, Inc. in the interactive database Compare manager voting policies
These tallies are MacroGenics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 20, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Scott Koenig, M.D., Ph.D. | 26,353,906 | -- | -- | 992,399 | 9,397,708 | 96% | Elected | — |
| Elect Director: Federica O'Brien | 26,467,370 | -- | -- | 878,935 | 9,397,708 | 97% | Elected | — |
| Elect Director: Eric Risser | 27,174,501 | -- | -- | 171,804 | 9,397,708 | 99.3% | Elected | — |
| 2. Approved | 36,689,683 | 40,552 | 13,778 | -- | -- | 99.8% | Approved | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement | 26,624,952 | 526,125 | 195,228 | -- | 9,397,708 | 98% | Approved | — |
| 4. To approve an amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan (the "2023 Plan") to increase the number of shares of our common stock available for issuance thereunder by 1,250,000 shares | 25,600,112 | 1,671,102 | 75,091 | -- | 9,397,708 | 94% | Approved | — |
Source: MacroGenics, Inc., Form 8-K, filed with the SEC on May 20, 2026 — read the filing on EDGAR.
Each item below shows how the 94 asset managers that disclosed a MacroGenics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MacroGenics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser
MacroGenics, Inc.’s own tally for this item (“Elect Director: Eric Risser”): 27,174,501 for, 171,804 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 7,124,720 for, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,824,636 | 0 | 1 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 33,173 | 0 | 0 | 0 | For |
| American Century | 30,556 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 6,690 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 334 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien
MacroGenics, Inc.’s own tally for this item (“Elect Director: Federica O'Brien”): 26,467,370 for, 878,935 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 7,118,028 for, 6,690 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,824,634 | 0 | 3 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 33,173 | 0 | 0 | 0 | For |
| American Century | 30,556 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 6,690 | Withhold |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 334 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D.
MacroGenics, Inc.’s own tally for this item (“Elect Director: Scott Koenig, M.D., Ph.D.”): 26,353,906 for, 992,399 withheld, per its Form 8-K filed May 20, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All director nominees were elected.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 7,124,718 for, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,824,634 | 0 | 3 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 33,173 | 0 | 0 | 0 | For |
| American Century | 30,556 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 6,690 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 334 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials.
MacroGenics, Inc.’s own tally for this item (“4. To approve an amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan (the "2023 Plan") to increase the number of shares of our common stock available for issuance thereunder by 1,250,000 shares”): 25,600,112 for, 1,671,102 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the amendment to the 2023 Plan.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 25 asset managers below reported 7,049,105 for, 97,216 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,819,674 | 4,963 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 0 | 33,173 | 0 | 0 | Against |
| American Century | 0 | 30,556 | 0 | 0 | Against |
| Rangeley Capital, LLC | 0 | 21,500 | 0 | 0 | Against |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 6,690 | 0 | 0 | Against |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 334 | 0 | 0 | Against |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 100 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.
MacroGenics, Inc.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement”): 26,624,952 for, 526,125 against — passed, per its Form 8-K filed May 20, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation of the Company's named executive officers.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,824,636 | 1 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 0 | 33,173 | 0 | 0 | Against |
| American Century | 0 | 30,556 | 0 | 0 | Against |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 6,690 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 334 | 0 | 0 | 0 | For |
Fund voting reports, all 23 managers: 7,060,991 for, 63,730 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,880,951 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,864,176 | 0 | 0 | 0 | For |
| Two Sigma | 1,709,975 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 1,646,267 | 43,276 | 0 | 0 | For |
| WASATCH ADVISORS LP | 1,558,296 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 1,221,496 | 0 | 0 | 0 | For |
| Renaissance | 1,025,481 | 0 | 0 | 0 | For |
| BlackRock | 835,662 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 697,321 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 597,442 | 0 | 0 | 0 | For |
| DE Shaw | 498,802 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 420,000 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 378,433 | 0 | 0 | 0 | For |
| Vanguard | 373,829 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 280,000 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 224,843 | 0 | 0 | 0 | For |
| Amundi | 0 | 214,278 | 0 | 0 | Against |
| PANAGORA ASSET MANAGEMENT INC | 184,910 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 179,122 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 168,029 | 0 | 0 | 0 | For |
| State Street | 160,051 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 118,356 | 0 | 0 | 0 | For |
| Dimensional | 110,893 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 92,224 | 0 | 0 | 0 | For |
Institutional-manager reports, all 79 managers: 16,849,474 for, 342,848 against, 400 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026.
The 23 asset managers below reported 7,122,383 for, 2,338 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,822,299 | 2,338 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 1,530,024 | 0 | 0 | 0 | For |
| Fidelity | 631,270 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 420,000 | 0 | 0 | 0 | For |
| BlackRock | 148,109 | 0 | 0 | 0 | For |
| Nationwide | 114,302 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 73,500 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,189 | 0 | 0 | 0 | For |
| GuideStone | 61,341 | 0 | 0 | 0 | For |
| Dimensional | 60,065 | 0 | 0 | 0 | For |
| Charles Schwab | 40,000 | 0 | 0 | 0 | For |
| Invesco | 33,173 | 0 | 0 | 0 | For |
| American Century | 30,556 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,167 | 0 | 0 | 0 | For |
| Jackson National | 18,398 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,900 | 0 | 0 | 0 | For |
| Prudential/PGIM | 10,990 | 0 | 0 | 0 | For |
| Equitable | 10,632 | 0 | 0 | 0 | For |
| Northern Trust | 6,690 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,463 | 0 | 0 | 0 | For |
| John Hancock | 1,532 | 0 | 0 | 0 | For |
| Allianz | 1,449 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 334 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 63,563,123 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.02% |
| 2 | WASATCH FUNDS TRUST | 2.41% |
| 3 | Fidelity | 0.99% |
| 4 | Delaware/Macquarie | 0.66% |
| 5 | BlackRock | 0.23% |
| 6 | Nationwide | 0.18% |
| 7 | BRIDGEWAY FUNDS INC | 0.12% |
| 8 | Columbia Threadneedle | 0.11% |
| 9 | GuideStone | 0.10% |
| 10 | Dimensional | 0.09% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 2.96% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 2.93% |
| 3 | Two Sigma | 2.69% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 2.66% |
| 5 | WASATCH ADVISORS LP | 2.45% |
| 6 | MARSHALL WACE, LLP | 1.92% |
| 7 | Renaissance | 1.61% |
| 8 | BlackRock | 1.31% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.10% |
| 10 | MACKENZIE FINANCIAL CORP | 0.94% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Armistice Capital, LLC | 7.88% | 13G |
| Vanguard Group | 6.65% | 13F |
| Renaissance Technologies | 4.66% | 13F |
| Millennium Management | 4.40% | 13F |
| BANK OF AMERICA CORP /DE/ | 4.02% | 13G |
| Two Sigma | 3.98% | 13F |
| Scott Koenig, M.D., Ph.D. | 2.30% | DEF14A |
| BlackRock | 1.83% | 13F |
| D.E. Shaw | 1.67% | 13F |
| Citadel Advisors | 1.32% | 13F |
Percentages above are of 63,563,123 shares outstanding, as reported by MacroGenics, Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MacroGenics, Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
MacroGenics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
proxyvotesnow.com, “MacroGenics (MGNX) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/macrogenics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.